Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Capsugel Unveils Quality Control Laboratory

Published: Monday, December 10, 2012
Last Updated: Monday, December 10, 2012
Bookmark and Share
South Carolina based facility provides global center of excellence for the company.

Capsugel has announced that it has doubled its laboratory capacity with the opening of its new Quality Control Laboratory in Greenwood, SC.

The new laboratory serves as a global resource to its extensive network of manufacturing sites and R&D laboratories located in Boston, Strasbourg and Colmar.

The company invested more than $3 million to create this facility that is the global center of excellence for quality control and testing of all raw materials and specialty testing of finished products for Capsugel sites around the world.

The facility’s opening marks a significant investment that demonstrates Capsugel’s commitment to designing, manufacturing, and delivering premiere healthcare products and services.

“Our new Quality Control Laboratory positions Capsugel for future growth in an increasingly complex regulatory marketplace,” says Guido Driesen, President & CEO of Capsugel.

Driesen continued, “Quality is the hallmark of our business and a core principle at Capsugel that provides added value to our customers. Our thorough testing equates to faster time to market as our products are designed to comply with today’s strict regulations.”

The 9,600 square foot facility is equipped to provide a wide range of analytical and microbial testing, as well as development of color formulations.

With the new capacity, Capsugel has expanded its Global Stability Program with walk-in stability chambers and photo stability chambers.

This critical equipment is used to support the shelf life of the finished products, to register new products in different countries, and to conduct excursion studies to determine the impact of different temperature and humidity conditions on the quality of the capsules.

By the time a product is considered ready for market, it may have gone through up to 23 individual quality tests at the company’s new Quality Control Laboratory.

The facility is the latest in a series of recent upgrades and expansions, as Capsugel grows to meet its increasing global demand for its high quality capsule products.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Capsugel and Pulmatrix Enter Collaboration to Develop and Manufacture Novel Inhaled Therapeutics
Company has announced the collaboration to develop novel inhaled therapeutics to treat serious pulmonary diseases.
Friday, February 19, 2016
Capsugel Completes Acquisitions of Xcelience and Powdersize
Acquisitions provide Capsugel with specialized clinical trial manufacturing and supply capabilities.
Thursday, January 07, 2016
Capsugel to Acquire Xcelience and Powdersize
Xcelience provides the company with specialized clinical trial manufacturing and supply capabilities for a broad range of solid dosage forms.
Thursday, December 17, 2015
Capsugel Expanding Pharmaceutical Product Development and Manufacturing Capabilities
Investment accommodates the company’s growing pipeline of pharmaceutical customer projects and brings a broader range of technologies closer to its European customers.
Thursday, August 06, 2015
Capsugel Unveils New Spray-Dried Dispersion Commercial Manufacturing Facility
Significantly expands the commercial manufacturing capability at its Bend, Ore. Site.
Thursday, July 02, 2015
Capsugel Extends Inhaled Biotherapeutics Delivery Capability to Phase 2 Clinical Trials
Company partnering with customers to expand the use of inhalation technologies to treat a wider range of diseases.
Thursday, May 07, 2015
Capsugel Awarded EXCiPACT™ Certifications
First hard capsule manufacturer to receive this important third-party recognition.
Wednesday, October 08, 2014
Capsugel and Cardax to Collaborate on Astaxanthin Products Development
Collaboration leverages Capsugel’s proprietary lipid-based technologies for potential development of consumer health products.
Thursday, August 21, 2014
Capsugel Expands Global Manufacturing for Finished Dosage Forms
DFS unit expands capabilities for hormonal, high-potency compounds.
Thursday, September 26, 2013
Capsugel to Acquire Bend Research
Enhances bioavailability expertise.
Thursday, September 12, 2013
Scientific News
New Database for Sharing MS Clinical Trial Data
A new database containing nearly 2500 patient records from the placebo arms of nine multiple sclerosis (MS) clinical trials is now available for research by qualified investigators.
Study Finds Factors That May Influence Influenza Vaccine Effectiveness
Researchers at NIH have suggested that the long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited.
BMS’s Opdivo Clinical Trial Shows Promise
Safety profile of the combination regimen from CheckMate -069 was consistent with previously reported studies and adverse events were managed using established safety algorithms.
Treatment of Common Prostate Cancer
Researchers at UTSW have found that the prostate cancer treatments suppress immune response and may promote relapse.
Cancer Drug Could Treat Blood Vessel Deformities
A drug currently being trialled in cancer patients could also be used to treat an often incurable condition that can cause painful blood vessel overgrowths inside the skin.
Structure of Crucial Enzyme Identified
Researchers at UTSW have determined the atomic structure of an enzyme that plays an essential role in cell division and better treatment of cancer.
New Immunotherapy Trial for Type 1 Diabetes
The search for a treatment for Type 1 diabetes (T1D) - which affects over 400,000 people in the UK – will be stepped up with the start of a new phase one clinical trial at Guy’s Hospital in London.
Recruitment of First Patient in Clinical Study
Company has announced recruitment of first patient in clinical study assessing Visco-ease with Beatson Cancer Centre for the treatment of RIX.
Fighting Prostate Cancer
Identifying the most promising compounds which can be used as medications for prostate cancer.
Chi-Med Initiates Sulfatinib Phase III Registration Study
Company has initiated SANET-p, a Phase III registration trial of sulfatinib with pancreatic neuroendocrine tumors (“NETs”).
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!